EMA Authorised: Leflunomide ratiopharm (leflunomide) — Ratiopharm GmbH

View source ↗

Summary

EMA authorised Leflunomide ratiopharm for rheumatoid arthritis; the product is manufactured by Ratiopharm GmbH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Leflunomide ratiopharm (leflunomide)

Snippet

Status: Authorised. Therapeutic area: Arthritis, Rheumatoid. MAH: Ratiopharm GmbH. Decision date: 18/12/2025